Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib significantly regrows hair in teens with severe alopecia areata.

ATP helps prevent skin damage from vandetanib by reducing stress.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

OnabotulinumtoxinA treatment improved hair-pulling disorder and hair regrowth in a woman with chronic migraines.

Amygdalin in Persicae Semen may help treat hair loss by promoting hair growth and regulating key pathways.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Blocking certain brain processes reduces mating behavior in female rats.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib is an effective and safe treatment for alopecia areata.

Naltrexone did not significantly reduce hair pulling but improved cognitive flexibility.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

PTH-CBD agonists may help regrow hair after chemotherapy.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Prostanoids, like prostaglandins and thromboxane A2, can both enhance and inhibit hair growth, and understanding their effects could help treat hair disorders.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.